Frontlight ResearchEarly access
Spinal muscular atrophy trials in Japan
2 of 4 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy Patients
- Where
- Fukuoka, Kodaira, Kyoto, Toyoake
- Age
- 2 years and over
- People
- 80
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07767890 - No phaseActive, not recruitingRegistry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
- Where
- Chiba, Fukui, Gifu, Hamamatsu, Hokkaido, Kita-gun, Kumamoto, Kurume-shi, Moriyama-shi, Nagakute-shi, Saitama, Sapporo, Sendai, Shimotsuke-shi, Shinjuku-ku, Shinjuku-Ku, Toyoake-shi, Yokohama
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04174157